Published October 27, 2017

Researchers followed 6,693 women with early stage breast cancer. These patients were randomly divided into two groups. One group received chemotherapy, and the other didn’t. After five years, only a handful of the patients who received chemotherapy had experienced a breast cancer relapse. The overwhelming majority were disease-free. The non-chemo group didn’t fare quite as well, leading the researchers to conclude that approximately one in four patients with small tumors are at risk of metastases.

Read More

Published October 25, 2017

Researchers recently conducted a study with 444 patients suffering from osteoarthritis or rheumatoid arthritis. They divided the patients into three groups, with each receiving a different pain-relieving drug. The groups that received ibuprofen and naproxen, both NSAIDs, saw average systolic blood pressure increases of 3.7 and 1.6 mmHg, respectively. Moreover, among the patients who had normal baseline blood pressure to begin with, 23.2% of those receiving ibuprofen and 19% of those receiving naproxen developed hypertension by the end of the study.

Read More

Published October 23, 2017

Researchers followed 180 men between the ages of 18 and 65 years with mild or moderate erectile dysfunction, and with or without complaints of low libido. For three months, they gave half of the men three capsules of Tribestan twice a day. They gave the other men a placebo. The International Index of Erectile Function questionnaire (IIEF) scores improved significantly in the Tribestan group. In fact, the scores in the men taking the Tribestan were almost three times better than the men taking the placebo. The Tribestran group also fared better statistically in their Global Efficacy Question (GEQ) scores and reported greater intercourse satisfaction, orgasmic function, libido, and overall satisfaction.

Read More